A new method to estimate the long-term effect of immunosuppressants and vasodilator therapies on lung function outcomes in systemic sclerosis patients

N. LE-DONG (Erpent, Belgium), T. Hua-Huy (Paris, France), T. Hoang-Thi (Paris, France), V. Codullo (Paris, France), Y. Allanore (Paris, France), A. Dinh-Xuan (Paris, France)

Source: Virtual Congress 2020 – Predictive markers of progression in connective tissue disease-associated interstitial lung disease and hypersensitivity pneumonitis

Session: Predictive markers of progression in connective tissue disease-associated interstitial lung disease and hypersensitivity pneumonitis
Session type: E-poster session
Number: 807

Disease area: Interstitial lung diseases

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
N. LE-DONG (Erpent, Belgium), T. Hua-Huy (Paris, France), T. Hoang-Thi (Paris, France), V. Codullo (Paris, France), Y. Allanore (Paris, France), A. Dinh-Xuan (Paris, France). A new method to estimate the long-term effect of immunosuppressants and vasodilator therapies on lung function outcomes in systemic sclerosis patients. 807

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.